Evaluating a Telemedicine-based Intensive Treatment Program for Children and Adolescents With Obesity

Sponsor
Sheba Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05700409
Collaborator
(none)
100
1
2
12
8.4

Study Details

Study Description

Brief Summary

The study objective is to evaluate whether a novel telemedicine-based intensive treatment program for children with obesity is superior to standard on-site care. This will be a randomized, non-blinded (due to the nature of the intervention) study, where 100 children and adolescents aged 10-18 years with obesity will be divided in a 1:1 ratio to either telemedicine or on-site treatments for 6 months.

The telemedicine arm will include 30, mostly video, consultations for each participant: 3 physician appointments, 7 exercise consultations by our exercise physiologist, 10 dietary consultations by our pediatric dietitian, and 10 psychologist consultations to assist with goal setting and overall well-being. Three visits will be conducted in-office, for physician assessment, smartphone technical assistance and physical measurements (baseline, at 3 months and at the end of the 6-month period). Participants randomized to the telemedicine arm will have a step-counting rewarding app installed on their smartphone by our staff.

The in-office arm will have 6 monthly visits during the study period, with two consultations performed in each visit - one by the physician or exercise physiologist, and one by our pediatric dietitian.

The main outcome of the study is BMI standard deviation (z-score) changes, which will be evaluated after 3 and 6 months of treatment during physical office visits in both study arms.

Secondary outcomes will be:
  • Body-fat percent changes, assessed by bioimpedance analysis in physical clinic visits.

  • Daily step counts, measured by smartphone data/ wearable activity tracker, if available.

  • Weight-related quality of life

  • Retention and visit cancellation rates.

  • Satisfaction of both parent and child from their allocated treatment.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Intensive lifestyle consultations
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluating a Telemedicine-based Intensive Treatment Program for Children and Adolescents With Obesity
Actual Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Telemedicine

The telemedicine arm will include 30, mostly video, consultations for each participant: 3 physician appointments, 7 exercise consultations by our exercise physiologist, 10 dietary consultations by our pediatric dietitian, and 10 psychologist consultations to assist with goal setting and overall well-being. Three visits will be conducted in-office, for physician assessment, smartphone technical assistance and physical measurements (baseline, at 3 months and at the end of the 6-month period). Participants randomized to the telemedicine arm will have a step-counting rewarding app installed on their smartphone by our staff.

Behavioral: Intensive lifestyle consultations
detailed above

Active Comparator: On-site

The on-site arm will have 6 monthly visits during the study period, with two consultations performed in each visit - one by the physician or exercise physiologist, and one by our pediatric dietitian.

Behavioral: Intensive lifestyle consultations
detailed above

Outcome Measures

Primary Outcome Measures

  1. Weight status [From baseline to 3 months]

    BMI z-score change

  2. Weight status [From baseline to 6 months]

    BMI z-score change

Secondary Outcome Measures

  1. Body-fat percent changes [From baseline to 3 months]

  2. Body-fat percent changes [From baseline to 6 months]

  3. Daily step counts [At 3 months]

  4. Daily step counts [At 6 months]

  5. Weight-related quality of life [Basline]

    Scores on the Impact of Weight on Quality of Life (IWQOL)-Kids questionnaire OR "Sizing me up" questionnaire

  6. Weight-related quality of life [3 months]

    Scores on the Impact of Weight on Quality of Life (IWQOL)-Kids questionnaire OR "Sizing me up" questionnaire

  7. Weight-related quality of life [6 months]

    Scores on the Impact of Weight on Quality of Life (IWQOL)-Kids questionnaire OR "Sizing me up" questionnaire

  8. Visit cancellation rates [6 months]

  9. Retention in program [6 months]

    Duration of participation in the program

  10. Satisfaction of allocated treatment [6 months]

    Generic PROM questionnaire used in our hopital

Eligibility Criteria

Criteria

Ages Eligible for Study:
10 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Obesity, defined as a BMI at or above 2 standard deviations SDs according to the WHO growth reference

  • Owning a smartphone, needed for video conversations, step counting and the gamification app

  • Parent consent and child's assent to participate in the program

Exclusion Criteria:
  • Significant physical or mental barriers to physical activity and/or to dietary changes (such as autistic spectrum disorder that precludes dietary changes or sufficient exercise, as assessed by the PI)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sheba Medical Center Ramat Gan State/Province Israel 52621

Sponsors and Collaborators

  • Sheba Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Gal Raz-Dubnov MD, MSc, Director, Pediatric LIfestyle Clinic, Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT05700409
Other Study ID Numbers:
  • SMC-21-8876
First Posted:
Jan 26, 2023
Last Update Posted:
Jan 26, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 26, 2023